IDEA Pharma, SAI MedPartners
Publishes 1 feed
IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is…
10 posts · theirs
Lately
Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory Strategy
The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.
The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping
Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds
Building the Future of Targeted Protein Degradation Medicines with Nello Mainolfi
AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartners
Rewriting the Future of Rare Disease: Engineered tRNA and a New Therapeutic Paradigm with Michelle Werner
Everything on this page was read from markup IDEA Pharma, SAI MedPartners published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON